Abstract
The paper is focused on the synthesis and screening of the antiplasmodial activity of novel fumardiamides 5–10 with the mefloquine pharmacophore and a Michael acceptor motif. Multi-step reactions leading to the title compounds included two amide bond formations. The first amide bond was achieved by the reaction of ( E )-ethyl 4-chloro-4-oxobut-2-enoate ( 1 ) and N 1 -(2,8-bis(trifluoromethyl)quinolin-4-yl) butane-1,4-diamine ( 2 ). The obtained ester 3 was hydrolyzed and gave acid 4 , which then reacted with the selected halogenanilines in the presence of HATU/DIEA and formed products 5–10 . Title compounds showed marked, dose dependent activity in vitro against hepatic stages of Plasmodium berghei. IC 50 values of the most active compounds 5 , 7 and 9 bearing 3-fluoro, 3-chloro and 3-trifluoromethyl substituents were 3.04–4.16 µmol L −1 , respectively. On the other hand, the compounds exerted only weak activity against the erythrocytic stages of two P. falciparum strains ( Pf 3D7 and Pf Dd2) in vitro , with the exception of compound 5 ( IC 50 = 2.9 µmol L −1 ).

This publication has 27 references indexed in Scilit: